Incyte Genomics
INCY
NASDAQ
IPO1993
about INCY
Incyte Genomics is a biopharmaceutical company focused on advancing innovative cancer treatments through precision medicine and oncology research, offering targeted therapies for patients with serious diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $92.16 | $93.17 | $90.69 | $17.82B | 3.80M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$2.09 | 70.22 | 15.39 | 43.63% | 33.32% | 0% |